myrkino.com
Fevipiprant : Promising asthma drug according to study - Myrkino
A new asthma drug, known as Fevipiprant (a prostaglandin D2 receptor antagonist) could revolutionize the treatment of the disease according to a new study.
Papageorgiou Antonis